These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3099815)

  • 21. Use of degradable and nondegradable nanomaterials for controlled release.
    Wan WK; Yang L; Padavan DT
    Nanomedicine (Lond); 2007 Aug; 2(4):483-509. PubMed ID: 17716133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Niosomes in sustained and targeted drug delivery: some recent advances.
    Azeem A; Anwer MK; Talegaonkar S
    J Drug Target; 2009 Nov; 17(9):671-89. PubMed ID: 19845484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prolonged-release drug formulations for parenteral administration. Part II. Microspheres and implants for injection].
    Płaczek M; Jacyna J; Sznitowska M
    Pol Merkur Lekarski; 2014 Jan; 36(211):54-8. PubMed ID: 24645581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Matrices for controlled liberation by swelling of polymers. II: Preparation of drug delivery systems and analysis of liberation kinetics].
    Gander B; Gurny R; Doelker E
    Pharm Acta Helv; 1986; 61(7):178-84. PubMed ID: 3737618
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo biocompatibility of three potential intraperitoneal implants.
    Defrère S; Mestagdt M; Riva R; Krier F; Van Langendonckt A; Drion P; Jérôme C; Evrard B; Dehoux JP; Foidart JM; Donnez J
    Macromol Biosci; 2011 Oct; 11(10):1336-45. PubMed ID: 21823236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physicochemical characteristics and in vitro release from oil-based vehicles of peptidomimetics: parenteral depots for intra-articular administration.
    Pedersen BT; Ostergaard J; Larsen SW; Cornett C; Ankersen M; Larsen C
    Drug Dev Ind Pharm; 2011 Jan; 37(1):62-71. PubMed ID: 20545510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomes as targetable drug carriers.
    Torchilin VP
    Crit Rev Ther Drug Carrier Syst; 1985; 2(1):65-115. PubMed ID: 3913530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymeric vehicles for topical delivery and related analytical methods.
    Cho HK; Cho JH; Jeong SH; Cho DC; Yeum JH; Cheong IW
    Arch Pharm Res; 2014 Apr; 37(4):423-34. PubMed ID: 24643380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrogel integrated with liposome: a two-stage drug delivery system.
    Liu Y; Liang D
    J Control Release; 2011 Nov; 152 Suppl 1():e63-4. PubMed ID: 22195929
    [No Abstract]   [Full Text] [Related]  

  • 30. Contact lenses as drug reservoirs & delivery systems: the successes & challenges.
    ElShaer A; Ghatora B; Mustafa S; Alany RG
    Ther Deliv; 2014 Oct; 5(10):1085-100. PubMed ID: 25418268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of antibodies. Polymers for the sustained release of macromolecules: their use in a single-step method of immunization.
    Langer R
    Methods Enzymol; 1981; 73(Pt B):57-75. PubMed ID: 7300688
    [No Abstract]   [Full Text] [Related]  

  • 32. A transcutaneous prosthesis for prolonged access to the peritoneal cavity.
    Striker GE; Tenckhoff HA
    Surgery; 1971 Jan; 69(1):70-4. PubMed ID: 5538952
    [No Abstract]   [Full Text] [Related]  

  • 33. Hydroxyapatite cement based drug delivery systems: drug release in vitro.
    Yu D; Tsai CL; Wong J; Fox JL
    J Formos Med Assoc; 1991 Oct; 90(10):953-7. PubMed ID: 1685176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term multicomponent enzyme therapy--a developing trend in the complex treatment of suppurative wounds].
    Adamian AA; Gliantsev SP
    Khirurgiia (Mosk); 1992; (7-8):105-14. PubMed ID: 1469859
    [No Abstract]   [Full Text] [Related]  

  • 35. Engineered polymers and polymeric systems in controlled drug delivery and targeting. Preface.
    Avgoustakis K
    Eur J Pharm Biopharm; 2009 Mar; 71(3):407-8. PubMed ID: 19150405
    [No Abstract]   [Full Text] [Related]  

  • 36. Protease-sensitive, polymer-caged liposomes: a method for making highly targeted liposomes using triggered release.
    Basel MT; Shrestha TB; Troyer DL; Bossmann SH
    ACS Nano; 2011 Mar; 5(3):2162-75. PubMed ID: 21314184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absorption of a parenteral diet from the peritoneal cavity.
    Bryant MS; Sinclair KG; Copeland EM; Ellis LM; Baumgartner TG; Sitren HS
    Curr Surg; 1987; 44(5):382-4. PubMed ID: 3121257
    [No Abstract]   [Full Text] [Related]  

  • 38. Delayed in vitro immune response to long-term intraperitoneal polymer implant in mice.
    Maurin N; Guernier C; Daty N
    J Biomed Mater Res; 1995 Dec; 29(12):1493-8. PubMed ID: 8600139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Fluorouracil in topical liposome gels for anticancer treatment--formulation and evaluation.
    Glavas-Dodov M; Fredro-Kumbaradzi E; Goracinova K; Calis S; Simonoska M; Hincal AA
    Acta Pharm; 2003 Dec; 53(4):241-50. PubMed ID: 14769231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Porous nanoparticles in drug delivery systems.
    Arayne MS; Sultana N
    Pak J Pharm Sci; 2006 Apr; 19(2):158-69. PubMed ID: 16751130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.